Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…
undefined
Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
December 17, 2024 21:55 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
undefined
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
undefined
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
undefined
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
undefined
Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million
December 02, 2024 18:22 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
undefined
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…
undefined
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…
undefined